RSS

Early Access to Medicine Scheme

The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has granted a positive opinion to Akcea Therapeutics’ volanesorsen for the treatment of familial chylomicronaemia syndrome (FCS) under the Early Access to Medicines Scheme (EAMS). more

News

Data published by the BioIndustry Association (BIA) has revealed that most healthcare professionals are not aware of government-led initiatives, such as the Accelerated Access Review, aimed at improving innovation adoption across the NHS. more

Analysis

Heart failure medicine LCZ696 (sacubitril valsartan) will be available to the NHS under the Early Access to Medicines Scheme (EAMS) more

News